Eine Kamera ist auf eine reflektierende Glasscheibe gerichtet.
© DZIF

News

All current DZIF news can be found here.

Esel
© Rasche

Hepatitis B: What people can learn from donkeys

The discovery of a previously unknown hepatitis B virus in donkeys and zebras opens up new opportunities for understanding the course of the disease. A global research consortium was able to show that

Christoph Lange untersucht einen Patienten
© DZIF/scienceRELATIONS

Tuberculosis: New biomarker indicates individual treatment duration

The treatment of tuberculosis (TB) is long, demanding, and expensive. In particular, the ever increasing emergence of resistant tuberculosis bacteria requires a lot of patience: In these cases, the

Hepatitis E virus
© Gadicherla und Johne, BfR, 2020

Hepatitis E viruses surviving in the ejaculate of chronically infected patients

Hepatitis E is an infectious disease of the liver found across the globe. It is caused by the hepatitis E virus and in most cases heals by itself. However, in patients with a suppressed immune system

Hepatitis B virions (orange coloured)
© CDC/Dr. Erskine Palmer

New combination therapy offers chance of healing hepatitis B

Around 260 million people, more than three percent of the global population, are chronically infected with the hepatitis B virus (HBV); in the long term, this often leads to complications such as

Bioproben
© HMGU/Kühn

Avoiding risks of infection after transplantation

Patients have a high risk of serious infections after organ or stem cell transplantation. The number of these complications is large, but too little is currently known about the links between

Staphylococcus aureus
© NIAID

Hope for a vaccination against Staphylococcus areus infections?

Staphylococcus aureus (S. aureus) ranks among the globally most important causes of infections in humans and is considered a dreaded hospital pathogen. Active and passive immunisation against multi

Alina Renz, Lina Widerspick und Andreas Dräger
© Uni Tübingen

SARS-CoV-2: Bioinformaticians discover a new weakness of the virus

The search for effective antiviral agents against the new coronavirus is in full swing. Using a novel approach, Tübingen bioinformaticians have now discovered a weakness in the virus that could be

SARS-CoV-2
© NIAID

New SARS-CoV-2 neutralizing antibody enters clinical phase

Cologne, Marburg, Braunschweig and Ingelheim, Germany, 18 December 2020 – Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research (DZIF) and Boehringer

Prof. Stephan Becker and Prof. Gerd Sutter
© Rolf K. Wegst und LMU München

DZIF prizes for translational infection research go to vaccine researchers

This year, the German Center for Infection Research (DZIF) is honouring two researchers who have been engaged in virus research for many years and are currently actively working on a vaccine against

Masernimpfvirus als Vektor
© PEI

Measles virus as vector for a COVID-19 vaccine.

As part of the research activities within the German Center for Infection Research (DZIF), scientists of the Paul-Ehrlich-Institut studied specific vaccine candidates against COVID-19. They are based